Melvin J. Yu

Melvin J. Yu

Auto-generated profile, based on publicly available information

Melvin J. Yu

Eisai Inc., Andover, MA, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2013 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
MYMelvin J. Yu
Melvin J. Yu
WZWanjun Zheng
Wanjun Zheng
BSBoris M. Seletsky
Boris M. Seletsky
Covering: 1993 to 2002 The synthesis of eribulin mesylate from microgram to multi-gram scale is described in this Highlight. Key coupling reactions include formation of the C30a to C1 carbon–carbon bond and macrocyclic ring closure through an intramolecular Nozaki–Hiyama–Kishi reaction.

1 May 2012
Verified
Journal Article
Closed access
MTMurray J Towle
Murray J Towle
KNKenichi Nomoto
Kenichi Nomoto
MAMakoto Asano
Makoto Asano
YKYoshito Kishi
Yoshito Kishi
MYMelvin J Yu
Melvin J Yu
BLBruce A. Littlefield
Bruce A. Littlefield

18 April 2013 in Journal of Cheminformatics
Verified
Journal Article
Open access
PDF file
MYMelvin J Yu
Melvin J Yu
There is a growing body of literature describing the properties of marketed drugs, the concept of drug-likeness and the vastness of chemical space. In that context, enumerative combinatorics with simple atomic components may be useful in the conception and design of structurally novel compounds for expanding and enhancing high-throughput screening (HTS) libraries.

27 November 2012 in Journal of Cheminformatics
Verified
Journal Article
Open access
PDF file
MYMelvin J Yu
Melvin J Yu
The early drug discovery phase in pharmaceutical research and development marks the beginning of a long, complex and costly process of bringing a new molecular entity to market. As such, it plays a critical role in helping to maintain a robust downstream clinical development pipeline. Despite its importance, however, to our knowledge there are no published in silico models to simulate the progression of discrete virtual projects through a discovery milestone system.

1 December 2012 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
MYMelvin J. Yu
Melvin J. Yu
WZWanjun Zheng
Wanjun Zheng
KTKaren Tendyke
Karen Tendyke